Anders Pettersson
32Patents
10h-index
31Co-inventors
75Inventor score
Filing activity: Aug 28, 1996 → Jun 10, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6759059B1 | Fentanyl composition for the treatment of acute pain | Human Necessities | 110 | Expired |
| US6761910B1 | Pharmaceutical composition for the treatment of acute disorders | Human Necessities | 48 | Expired |
| US8470361B2 | Non-abusable pharmaceutical composition comprising opioids | Human Necessities | 29 | Active |
| US8400796B2 | Power converter with distributed cell control | Emerging Cross-Sectional Technologies | 24 | Active |
| US6113875A | Diagnostic preparation for detection of helicobacter pylori | Human Necessities | 19 | Expired |
| US7785626B2 | Gastric acid secretion inhibiting composition | Human Necessities | 17 | Expired |
| US8454996B2 | Pharmaceutical composition for the treatment of acute disorders | Human Necessities | 15 | Active |
| US8658198B2 | Non-abusable pharmaceutical composition comprising opioids | Human Necessities | 15 | Active |
| US8543263B2 | Distributed avionics | Electricity | 12 | Active |
| US8815911B2 | Alfentanil composition for the treatment of acute pain | Human Necessities | 10 | Active |
| US5900428A | Pharmacological use of AII-receptor antagonists | Human Necessities | 9 | Expired |
| US8980305B2 | Non-abusable pharmaceutical composition comprising opioids | Human Necessities | 8 | Active |
| US6096772A | Use of Angiotensin II type 1 receptor antagonists in the treatment of dyspeptic symptoms | Human Necessities | 5 | Expired |
| US5977159A | Medical use of an ace-inhibitor for treatment of dyspeptic symptoms | Chemistry; Metallurgy | 5 | Expired |
| US7815940B2 | Gastric acid secretion inhibiting composition | Human Necessities | 4 | Expired |
| US9384529B2 | Flight data display | Physics | 3 | Active |
| US8391958B2 | Method and arrangement relating to testing objects | Human Necessities | 3 | Active |
| US7910132B2 | Pharmaceutical composition for the treatment of acute disorders | Human Necessities | 2 | Active |
| US6083756A | Prevention of sudden infant death | Emerging Cross-Sectional Technologies | 2 | Expired |
| US9345698B2 | Alfentanil composition for the treatment of acute pain | Human Necessities | 1 | Active |
| US9172589B2 | Method for configuring a distributed avionics control system | Physics | 1 | Active |
| US7449205B2 | Banana coating for enhanced quality on storage and shipping | Human Necessities | 0 | Active |
| US11850522B2 | Facilitating rhythm-based user input with enhanced feedback and audio tracks | Human Necessities | 0 | Active |
| US9782396B2 | Alfentanil composition for the treatment of acute pain | Human Necessities | 0 | Active |
| US7771747B2 | Gastric acid secretion inhibiting composition | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.